- Home
- JVA vs RDHL Comparison
JVA vs RDHL Comparison
Compare JVA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JVA | RDHL |
|---|---|---|
| Founded | 1971 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8M | 4.2M |
| IPO Year | 1997 | 2012 |
Fundamental Metrics
Financial Performance| Metric | JVA | RDHL |
|---|---|---|
| Price | $3.44 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 46.9K | ★ 60.1K |
| Earning Date | 06-12-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $90,655,294.00 | N/A |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.30 | ★ N/A |
| Revenue Growth | ★ 17.54 | N/A |
| 52 Week Low | $2.93 | $0.63 |
| 52 Week High | $5.62 | $2.79 |
Technical Indicators
Market Signals| Indicator | JVA | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 42.39 |
| Support Level | $3.26 | $0.64 |
| Resistance Level | $3.78 | $0.73 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 60.00 | 26.67 |
Price Performance
Historical ComparisonAbout JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.